Shanahan Capital Ventures Provides Growth Capital to Oncology Plus Incorporated

November 3, 2010

Oncology Plus is pleased to announce that Shanahan Capital Ventures, an angel fund with extensive specialty oncology pharmacy experience, has invested in the Company to provide capital for future growth and the development of new business lines that extend beyond outsourced chemotherapy admixture.

OPI realizes that the delivery of high-quality, cost-effective care is increasingly challenging in the evolving healthcare landscape, but both SCV and OPI are excited about the vision for the future of OPI as the paradigm for the cancer care continues to shift. The collective capabilities of the Principals of SCV will assist in helping our customers achieve the business and clinical innovations required to advance their success and ensure the best possible care experience for patients.

The unified organization will bring together the collective expertise of OPI and SCV to provide a broad array of oncology services, including access to:

• Leading evidence-based medicine offerings that enable the demonstration of quality and facilitate value-driven reimbursement,
• Full service oral oncology platform,
• Innovative practice-management solutions and consultative capabilities that allow independent community specialists to thrive in a changing healthcare environment.

Through its partnership with SCV, Oncology Plus is dedicated to continually developing innovative new approaches to confronting cancer, increasing the effectiveness of care, and improving patient outcomes and experiences.